Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

  1. Lin, Y.
  2. Qiu, L.
  3. Usmani, S.
  4. Joo, C.W.
  5. Costa, L.
  6. Derman, B.
  7. Du, J.
  8. Einsele, H.
  9. Fernandez de Larrea, C.
  10. Hajek, R.
  11. Ho, P.J.
  12. Kastritis, E.
  13. Martinez-Lopez, J.
  14. Mateos, M.-V.
  15. Mikhael, J.
  16. Moreau, P.
  17. Nagarajan, C.
  18. Nooka, A.
  19. O'Dwyer, M.
  20. Schjesvold, F.
  21. Sidana, S.
  22. van de Donk, N.W.
  23. Weisel, K.
  24. Zweegman, S.
  25. Raje, N.
  26. Otero, P.R.
  27. Anderson, L.D.
  28. Kumar, S.
  29. Martin, T.
  30. Mostra tots els autors/es +
Revista:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Any de publicació: 2024

Tipus: Revisió

DOI: 10.1016/S1470-2045(24)00094-9 GOOGLE SCHOLAR